reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Signed by the Governor on 2026-03-10 H.J. 547

Delivered to the Governor on 2026-03-05 H.J. 520

Signed by the President S.J. 470

Signed by the Speaker H.J. 492

Senate Do Pass , Passed, YEAS 21, NAYS 12 S.J. 429

Remove from Consent Calendar S.J. 412

Certified uncontested, placed on consent , Passed, S.J. 21

Scheduled for hearing S.J. 1

Health and Human Services Do Pass , Passed, YEAS 6, NAYS 0 S.J. 21

First read in Senate and referred to Senate Health and Human Services S.J. 234

House of Representatives Do Pass , Passed, YEAS 58, NAYS 7 H.J. 265

Health and Human Services Do Pass , Passed, YEAS 13, NAYS 0 H.J. 13

Scheduled for hearing H.J. 1

First read in House and referred to House Health and Human Services H.J. 104